Park National Corp OH reduced its position in Clorox Company (The) (NYSE:CLX) by 5.4% during the second quarter, according to its most recent disclosure with the SEC. The fund owned 5,146 shares of the company’s stock after selling 294 shares during the period. Park National Corp OH’s holdings in Clorox Company (The) were worth $686,000 as of its most recent filing with the SEC.

Other institutional investors have also recently modified their holdings of the company. BlackRock Inc. boosted its position in shares of Clorox Company (The) by 1,402.2% in the first quarter. BlackRock Inc. now owns 10,390,206 shares of the company’s stock worth $1,400,912,000 after buying an additional 9,698,542 shares during the last quarter. Parnassus Investments CA purchased a new position in shares of Clorox Company (The) during the first quarter worth about $434,255,000. Vanguard Group Inc. boosted its position in shares of Clorox Company (The) by 4.8% in the first quarter. Vanguard Group Inc. now owns 14,164,716 shares of the company’s stock worth $1,909,829,000 after buying an additional 649,766 shares during the last quarter. Morgan Stanley boosted its position in shares of Clorox Company (The) by 31.9% in the first quarter. Morgan Stanley now owns 996,369 shares of the company’s stock worth $134,342,000 after buying an additional 241,210 shares during the last quarter. Finally, WINTON GROUP Ltd boosted its position in shares of Clorox Company (The) by 762.4% in the first quarter. WINTON GROUP Ltd now owns 228,197 shares of the company’s stock worth $28,566,000 after buying an additional 201,737 shares during the last quarter. 69.83% of the stock is owned by institutional investors and hedge funds.

Shares of Clorox Company (CLX) traded up 0.41% during mid-day trading on Friday, hitting $137.73. The company had a trading volume of 734,445 shares. Clorox Company has a 52 week low of $111.24 and a 52 week high of $141.76. The firm has a market capitalization of $17.78 billion, a PE ratio of 25.82 and a beta of 0.40. The firm has a 50-day moving average price of $133.55 and a 200-day moving average price of $134.12.

Clorox Company (The) (NYSE:CLX) last posted its quarterly earnings data on Thursday, August 3rd. The company reported $1.53 EPS for the quarter, topping the consensus estimate of $1.49 by $0.04. The firm had revenue of $1.65 billion during the quarter, compared to analyst estimates of $1.65 billion. Clorox Company (The) had a return on equity of 190.67% and a net margin of 11.74%. Clorox Company (The)’s revenue was up 2.9% on a year-over-year basis. During the same period in the prior year, the business posted $1.30 EPS. Equities analysts forecast that Clorox Company will post $5.67 earnings per share for the current year.

WARNING: “Park National Corp OH Has $686,000 Stake in Clorox Company (The) (NYSE:CLX)” was originally published by The Cerbat Gem and is the property of of The Cerbat Gem. If you are viewing this story on another domain, it was stolen and reposted in violation of US and international trademark & copyright legislation. The legal version of this story can be accessed at https://www.thecerbatgem.com/2017/08/19/park-national-corp-oh-cuts-position-in-clorox-company-the-nyseclx-updated-updated-updated.html.

A number of research firms have commented on CLX. Jefferies Group LLC reiterated a “hold” rating and issued a $137.00 price target (up previously from $136.00) on shares of Clorox Company (The) in a research report on Wednesday, August 9th. Royal Bank Of Canada reiterated a “hold” rating and issued a $115.00 price target on shares of Clorox Company (The) in a research report on Wednesday, August 2nd. Zacks Investment Research lowered Clorox Company (The) from a “buy” rating to a “hold” rating in a research report on Monday, July 31st. BidaskClub lowered Clorox Company (The) from a “sell” rating to a “strong sell” rating in a research report on Monday, July 24th. Finally, Barclays PLC restated an “equal weight” rating and set a $136.00 target price (down previously from $140.00) on shares of Clorox Company (The) in a research report on Friday, August 4th. Two investment analysts have rated the stock with a sell rating, ten have assigned a hold rating and three have issued a buy rating to the company. Clorox Company (The) has a consensus rating of “Hold” and an average price target of $129.05.

Clorox Company (The) Company Profile

The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.

Institutional Ownership by Quarter for Clorox Company (The) (NYSE:CLX)

Receive News & Stock Ratings for Clorox Company (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox Company (The) and related stocks with our FREE daily email newsletter.